1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
611FC9ACE5671B742002585DF0042DFF6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/11FC9ACE5671B742002585DF0042DFF6?OpenDocument
18
19OpenDocument
203.226.72.118
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Product Launch Excellence

Document Excerpt: COVID-19 Challenges for Product Launch Timelines and Activities (including launch case studies on Nexletol, Trodelvy, Vumerity, and Zeposia)

DB Image

Excerpt in Cart

ID: MD-733


Features:

35 Info Graphics

16 Data Graphics

230+ Metrics

67 Narratives


Pages/Slides: 5


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5633 "COVID-19 Challenges for Product Launch Timelines and Activities”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Diagnostic; Health Care; Consulting; Medical Device; Clinical Research; Laboratories


Companies Profiled:
AMAG Pharmaceuticals; Almirall; Alkermes; Amicus Therapeutics; Ascend Therapeutics; Asklepion Pharmaceuticals; LLC; Aspen Pharmacare; Astellas; Avadel Pharmaceuticals; Biofrontera; Bracco Diagnostics Inc.; Catalyst Pharmaceuticals; Celyad; Deciphera Pharmaceuticals; Eisai; FerGene; Ferring Pharmaceuticals; Kyowa Kirin; Merck; Milestone Pharmaceuticals; Mirador Global LP; Mission Bio; Nobio; Novartis; Novo Nordisk; Osmotica Pharmaceuticals; QED Therapeutics; Roche; Sanofi; Santhera Pharmaceuticals; Scilex Pharmaceuticals; Inc.; Servier; Shionogi Inc.; Sunovion; Supernus; Takeda Pharmaceuticals; TerSera Therapeutics; TG Therapeutics; Vifor Pharma; Visioneering Technologies Inc.; Zosano Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.